Summary
Further key aspects of the report:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Poxviridae Infections Drug market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Poxviridae Infections Drug market segmented into
CJ-40011
24a
BA-368
Others
Based on the end-use, the global Poxviridae Infections Drug market classified into
Hospital
Clinic
Others
Based on geography, the global Poxviridae Infections Drug market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Bavarian Nordic A/S
BioFactura, Inc.
CEL-SCI Corporation
Chimerix, Inc.
China Biologic Products, Inc.
CJ HealthCare Corp.
EpiVax, Inc.
N & N Pharmaceuticals Inc.
SIGA Technologies, Inc.
Takeda Pharmaceutical Company Limited
Tonix Pharmaceuticals Holding Corp.
Verrica Pharmaceuticals Inc.
End of Summary
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL POXVIRIDAE INFECTIONS DRUG INDUSTRY
2.1 Summary about Poxviridae Infections Drug Industry
2.2 Poxviridae Infections Drug Market Trends
2.2.1 Poxviridae Infections Drug Production & Consumption Trends
2.2.2 Poxviridae Infections Drug Demand Structure Trends
2.3 Poxviridae Infections Drug Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 CJ-40011
4.2.2 24a
4.2.3 BA-368
4.2.4 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospital
4.3.2 Clinic
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 CJ-40011
5.2.2 24a
5.2.3 BA-368
5.2.4 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospital
5.3.2 Clinic
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 CJ-40011
6.2.2 24a
6.2.3 BA-368
6.2.4 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospital
6.3.2 Clinic
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 CJ-40011
7.2.2 24a
7.2.3 BA-368
7.2.4 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospital
7.3.2 Clinic
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 CJ-40011
8.2.2 24a
8.2.3 BA-368
8.2.4 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospital
8.3.2 Clinic
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 CJ-40011
9.2.2 24a
9.2.3 BA-368
9.2.4 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospital
9.3.2 Clinic
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Bavarian Nordic A/S
10.1.2 BioFactura, Inc.
10.1.3 CEL-SCI Corporation
10.1.4 Chimerix, Inc.
10.1.5 China Biologic Products, Inc.
10.1.6 CJ HealthCare Corp.
10.1.7 EpiVax, Inc.
10.1.8 N & N Pharmaceuticals Inc.
10.1.9 SIGA Technologies, Inc.
10.1.10 Takeda Pharmaceutical Company Limited
10.1.11 Tonix Pharmaceuticals Holding Corp.
10.1.12 Verrica Pharmaceuticals Inc.
10.2 Poxviridae Infections Drug Sales Date of Major Players (2017-2020e)
10.2.1 Bavarian Nordic A/S
10.2.2 BioFactura, Inc.
10.2.3 CEL-SCI Corporation
10.2.4 Chimerix, Inc.
10.2.5 China Biologic Products, Inc.
10.2.6 CJ HealthCare Corp.
10.2.7 EpiVax, Inc.
10.2.8 N & N Pharmaceuticals Inc.
10.2.9 SIGA Technologies, Inc.
10.2.10 Takeda Pharmaceutical Company Limited
10.2.11 Tonix Pharmaceuticals Holding Corp.
10.2.12 Verrica Pharmaceuticals Inc.
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Tables and Figures
List of Table
Table Poxviridae Infections Drug Product Type Overview
Table Poxviridae Infections Drug Product Type Market Share List
Table Poxviridae Infections Drug Product Type of Major Players
Table Brief Introduction of Bavarian Nordic A/S
Table Brief Introduction of BioFactura, Inc.
Table Brief Introduction of CEL-SCI Corporation
Table Brief Introduction of Chimerix, Inc.
Table Brief Introduction of China Biologic Products, Inc.
Table Brief Introduction of CJ HealthCare Corp.
Table Brief Introduction of EpiVax, Inc.
Table Brief Introduction of N & N Pharmaceuticals Inc.
Table Brief Introduction of SIGA Technologies, Inc.
Table Brief Introduction of Takeda Pharmaceutical Company Limited
Table Brief Introduction of Tonix Pharmaceuticals Holding Corp.
Table Brief Introduction of Verrica Pharmaceuticals Inc.
Table Products & Services of Bavarian Nordic A/S
Table Products & Services of BioFactura, Inc.
Table Products & Services of CEL-SCI Corporation
Table Products & Services of Chimerix, Inc.
Table Products & Services of China Biologic Products, Inc.
Table Products & Services of CJ HealthCare Corp.
Table Products & Services of EpiVax, Inc.
Table Products & Services of N & N Pharmaceuticals Inc.
Table Products & Services of SIGA Technologies, Inc.
Table Products & Services of Takeda Pharmaceutical Company Limited
Table Products & Services of Tonix Pharmaceuticals Holding Corp.
Table Products & Services of Verrica Pharmaceuticals Inc.
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Poxviridae Infections Drug Market Forecast (Million USD) by Region 2021f-2026f
Table Global Poxviridae Infections Drug Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Poxviridae Infections Drug Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Poxviridae Infections Drug Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global Poxviridae Infections Drug Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Poxviridae Infections Drug Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Poxviridae Infections Drug Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Poxviridae Infections Drug Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Poxviridae Infections Drug Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Poxviridae Infections Drug Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Poxviridae Infections Drug Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CJ-40011 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 24a Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure BA-368 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CJ-40011 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 24a Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure BA-368 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CJ-40011 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 24a Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure BA-368 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CJ-40011 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 24a Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure BA-368 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CJ-40011 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 24a Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure BA-368 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CJ-40011 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 24a Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure BA-368 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Poxviridae Infections Drug Sales Revenue (Million USD) of Bavarian Nordic A/S 2017-2020e
Figure Poxviridae Infections Drug Sales Revenue (Million USD) of BioFactura, Inc. 2017-2020e
Figure Poxviridae Infections Drug Sales Revenue (Million USD) of CEL-SCI Corporation 2017-2020e
Figure Poxviridae Infections Drug Sales Revenue (Million USD) of Chimerix, Inc. 2017-2020e
Figure Poxviridae Infections Drug Sales Revenue (Million USD) of China Biologic Products, Inc. 2017-2020e
Figure Poxviridae Infections Drug Sales Revenue (Million USD) of CJ HealthCare Corp. 2017-2020e
Figure Poxviridae Infections Drug Sales Revenue (Million USD) of EpiVax, Inc. 2017-2020e
Figure Poxviridae Infections Drug Sales Revenue (Million USD) of N & N Pharmaceuticals Inc. 2017-2020e
Figure Poxviridae Infections Drug Sales Revenue (Million USD) of SIGA Technologies, Inc. 2017-2020e
Figure Poxviridae Infections Drug Sales Revenue (Million USD) of Takeda Pharmaceutical Company Limited 2017-2020e
Figure Poxviridae Infections Drug Sales Revenue (Million USD) of Tonix Pharmaceuticals Holding Corp. 2017-2020e
Figure Poxviridae Infections Drug Sales Revenue (Million USD) of Verrica Pharmaceuticals Inc. 2017-2020e